Viewing Study NCT01465503


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-02-12 @ 5:27 AM
Study NCT ID: NCT01465503
Status: COMPLETED
Last Update Posted: 2014-04-08
First Post: 2011-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients
Sponsor: Clinica Mediterranea
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bleeding View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bleeding View
None percutaneous coronary intervention View
None heparin View
None bivalirudin View